TrialJournal of the American Heart Association2024

Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study.

Ahmad Masri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.